Compliance to six weeks supplementation of a nutritional concept constituted as a powder in HIV-1 positive adults not on Highly Active Anti-Retroviral Therapy (HAART)

ISRCTN ISRCTN03460688
DOI https://doi.org/10.1186/ISRCTN03460688
Secondary identifying numbers 100172
Submission date
04/04/2011
Registration date
19/05/2011
Last edited
20/05/2011
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Infections and Infestations
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Ms Barbara Mourmans
Scientific

Bosrandweg 20
Wageningen
6704 PH
Netherlands

Study information

Study designOpen-label single-centre pilot study
Primary study designInterventional
Secondary study designNon randomised controlled trial
Study setting(s)Hospital
Study typeQuality of life
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleCompliance to six weeks supplementation of a nutritional concept constituted as a powder in HIV-1 positive adults not on Highly Active Anti-Retroviral Therapy (HAART): an open-label single-centre pilot study
Study acronymComBaT II
Study objectivesExploratory study to assess whether the product format (nutritional powder) is suitable for long term use in the target population
Ethics approval(s)Independent Review Board Nijmegen, the Netherlands approved on 25th September 2006
Health condition(s) or problem(s) studiedHuman immunodeficiency virus (HIV)-1
InterventionDuration of intervention: 6 weeks
Week 1: One sachet containing 45 grams of powder daily
Week 2-6: One sachet containing 45 grams of powder twice daily
The powder had to be dissolved in at least 100 ml cold water or cold dairy products before consumption.
Intervention typeOther
Primary outcome measure1. Compliance to intake of a powder
1.1. Total number of study product consumed in 6 weeks
1.2. Average daily intake of study product
1.3. Average weekly intake of study product
1.4. Period of intake of study product
1.5. Change in intake of study product during the study)
Secondary outcome measuresThe effect of intake of the powder on:
1. Gastrointestinal tolerance (assessed at baseline, week 3 and week 6)
2. Gut health parameters (assessed at baseline and week 6)
3. Appreciation of the nutritional powder (assessed after first consumption, week 1, week 3 and week 6)

Compare compliance to intake of the powder with compliance to intake of the nutritional bar analysed in the ComBaT study
Overall study start date16/10/2006
Completion date27/12/2006

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants30 planned, 24 actual
Key inclusion criteria1. Human immunodeficiency virus (HIV)-1 positive adults who have not received HAART in the past year and are not anticipated to start HAART during the study period
2. Age 18 years and older
3. Males and non-pregnant, non-lactating females
4. CD4+ T-cell count 350 cells/µL or higher
5. Written informed consent
Key exclusion criteria1. Lactose intolerance (not using a stable dose of lactase) or known allergy for any of the ingredients
2. Unable to adhere to protocol instructions (including illiterate persons)
3. Known inflammatory bowel diseases, coeliac disease
4. Investigators' uncertainty about the willingness or ability of the subject to comply with the protocol requirements [including intravenous (IV) drug users]
5. Participation in any other studies involving investigational or marketed products concomitantly or within two weeks prior to entry into the study and during the course of the study
Date of first enrolment16/10/2006
Date of final enrolment27/12/2006

Locations

Countries of recruitment

  • Netherlands

Study participating centre

Bosrandweg 20
Wageningen
6704 PH
Netherlands

Sponsor information

Danone Research (Netherlands)
Research organisation

Centre for Specialised Nutrition
Bosrandweg 20
Wageningen
6704 PH
Netherlands

Phone +31(0)31 746 7800
Email barbara.mourmans@danone.com
ROR logo "ROR" https://ror.org/01c5aqt35

Funders

Funder type

Research organisation

Danone Research B.V. (Netherlands) – Centre for Specialised Nutrition

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan